The ATM Gene Protein: Possible Roles in Genome Surveillance, Checkpoint Controls Cellular Defence against Oxidative Stress

Cancer Surveys

Volumn 29, Issue , 1997, Pages 285-304

  Rotman, Galit ^a   Shiloh, Yosef ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; IONIZING RADIATION; OXIDATIVE STRESS; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW;

ATAXIA TELANGIECTASIA; CELL CYCLE; CELL CYCLE PROTEINS; CHROMOSOME BREAKAGE; DNA DAMAGE; DNA-BINDING PROTEINS; GENES, P53; HUMANS; OXIDATIVE STRESS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0030985116     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (179)

1. Agarwal ML, Agarwal A, Taylor WR and Stark GR (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proceedings of the National Academy of Sciences of the USA 92 8493-8497
2. Anderson CW (1993) DNA damage and the DNA-activated protein kinase. Trends in Biochemical Sciences 18 433-437
3. Anderson CW and Carter TH (1996) The DNA-activated protein kinase-DNA-PK. Current Topics in Microbiology and Immunology 217 91-111
4. Arlett CF and Priestley A (1983) Defective recovery from potentially lethal damage in some human fibroblast cell strains. International Journal of Radiation Biology 43 157-167
5. Arlett CF and Priestley A (1985) An assessment of the radiosensitivity of ataxia-telangiectasia heterozygotes, In: Gatti RA and Swift M (eds). Ataxia-Telangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood, pp 101-109, Alan R Liss, New York
6. Baeuerle PA and Henkel T (1994) Function and activation of NF-κB in the immune system. Annual Review of Immunology 12 141-179
7. Barak Y, Juven T, Haffner R and Oren M (1993) mdm2 expression is induced by wild type p53 activity. EMBO Journal 12 461-468
8. Bates S and Vousden KH (1996) p53 in signaling checkpoint arrest or apoptosis. Current Opinion in Genetics and Development 6 12-19
9. Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Annals of Neurology 38 357-366
10. Beamish H and Lavin MF (1994) Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. International Journal of Radiation Biology 65 175-184
11. Beamish H, Khanna KK and Lavin MF (1994) Ionizing radiation and cell cycle progression in ataxia-telangiectasia. Radiation Research 138 130-133
12. Beamish H, Williams R, Chen P and Lavin MF (1996) Defect in multiple cell cycle checkpoints in ataxia-telangiectasia post-irradiation. Journal of Biological Chemistry 271 20786-20793
13. Beckman JS and Crow JP (1993) Pathological implications of nitric oxide, Superoxide and peroxynitrite formation. Biochemical Society Transactions 21 330-334
14. Beckman JS, Carson M, Smith CD and Koppenol WH (1993) ALS, SOD and peroxynitrite. Nature 364 584
15. Bosma MJ and Carroll AM (1991) The SCID mouse mutant: definition, characterization, and potential uses. Annual Review of Immunology 9 323-350
16. Brach MA, Hass R, Sherman ML, Gunji H, Weichselbaum R and Kufe D (1991) Ionizing radiation induces expression and binding activity of the nuclear factor κB. Journal of Clinical Investigation 88 691-695
17. Brown EJ, Albers MW, Shin TB et al (1994) A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369 756-758
18. Brown EJ, Beal PA, Keith CT, Chen J, Shin TB and Schreiber SL (1995) Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature 377 441-446
19. Brown K, Park S, Kanno T, Franzoso G and Siebenlist U (1993) Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proceedings of the National Academy of Sciences of the USA 90 2532-2536
20. Brown K, Gerstberger S, Carlson L, Franzoso G and Siebenlist U (1995) Control of IκB-α proteolysis by site-specific signal-induced phosphorylation. Science 267 1485-1488
21. Buttke TM and Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunology Today 157-10
22. Byrd PJ, McConville CM, Cooper P et al (1996) Mutations revealed by sequencing the 5′ half of the gene for ataxia-telangiectasia. Human Molecular Genetics 5 145-149
23. Cafferkey R, Young PR, McLaughlin MM et al (1993) Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Molecular and Cellular Biology 13 6012-6023
24. Canman CE, Wolff AC, Chen CY, Fornace AJ and Kastan MB (1994) The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Research 54 5054-5058
25. Carpenter CL and Cantley LC (1996) Phosphoinositide kinases. Current Opinion in Cell Biology 8 153-158
26. Waf1/ciP1 with PCNA. Oncogene 11 1931-1937
27. Chen J, Lin J and Levine AJ ( 1995) Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Molecular Medicine 1 142-152
28. Chiao PJ, Miyamoto S and Verma IM (1994) Autoregulation of IκBα activity. Proceedings of the National Academy of Sciences of the USA 91 28-32
29. Cimprich KA, Shin TB, Keith CT and Schreiber SL (1996) cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proceedings of the National Academy of Sciences of the USA 93 2850-2855
30. Cox LS and Lane DP (1995) Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. BioEssays 17 501-508
31. Cox R, Masson WK, Weichselbaum RR, Nove J and Little JB (1981) The repair of potentially lethal damage in X-irradiated cultures of normal and ataxia-telangiectasia human fibroblasts. International Journal of Radiation Biology 39357-365
32. Cross SM, Sanchez CA, Morgan CA et al (1995) A p53-dependent mouse spindle checkpoint. Science 267 1353-1356
33. Dawson VL and Dawson TM (1996) Nitric oxide in neuronal degeneration. Proceedings of the Society for Experimental Biology and Medicine 211 33-40
34. Dean SW and Jaspers NGJ (1988) Impaired glutathione biosynthesis in cultured ataxia-telangiectasia cells. Cancer Research 48 5374-5376
35. De Caterina R, Libby P, Peng HB et al (1995) Nitric oxide decreases cytokine-induced endothelial activation. Journal of Clinical Investigation 96 60-68
36. DiDonato J, Mercurio F, Rosette C et al (1996) Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Molecular and Cellular Biology 16 1295-1304
37. Din S, Brill SJ, Fairman MP and Stillman B (1990) Cell-cycle-regulated phosphorylation of DNA replication factor A from human and yeast cells. Genes and Development 4 968-977
38. Dulic V, Kaufmann WK, Wilson SJ et al (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76 1013-1023
39. Dutta A and Stillman B (1992) cdc2 family kinases phosphorylate a human cell DNA replication factor, RPA, and activate DNA replication. EMBO Journal 11 2189-2199
40. Dutta A, Ruppert JM, Aster JC and Winchester E (1993) Inhibition of DNA replication factor RPA by p53. Nature 365 79-82
41. Easton DF (1994) Cancer risks in A-T heterozygotes. International Journal of Radiation Biology 66 S177-S182
42. E1-Deiry WS, Harper JW, O'Connor PM et al (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Research 54 1169-1174
43. Emerit I and Cerutti PA (1982) Tumor promoter phorbol 12-myristate 13-acetate induces a clastogenic factor in human lymphocytes. Proceedings of the National Academy of Sciences of the USA 79 7509-7513
44. Farias-Eisner R, Chaudhuri G, Aeberhard E and Fukuto JM (1996) The chemistry and tumoricidal activity of nitric oxide/hydrogen peroxide and the implications to cell resistance/susceptibility. Journal of Biological Chemistry 271 6144-6151
45. Forrester K, Ambs S, Lupold SE et al (1996) Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proceedings of the National Academy of Sciences of the USA 93 2442-2447
46. Gatti RA (1991) Localizing the genes for ataxia-telangiectasia: a human model for inherited cancer susceptibility. Advances in Cancer Research 56 77-104
47. Gatti RA, Berkel I, Boder E et al (1988) Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336 577-580
48. Gilad S, Khosravi R, Shkedy D et al (1996) Predominance of null mutations in ataxiatelangiectasia. Human Molecular Genetics 5 433-439
49. Greenlund LJS, Deckwerth TL and Johnson EM (1995) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14 303-315
50. Greenwell PW, Kronmal SL, Porter SE, Gassenhuber J, Obermaier B and Petes TD (1995) TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia-telangiectasia gene. Cell 82 823-829
51. Gross SS and Wolin MS (1995) Nitric oxide: pathophysiological mechanisms. Annual Review of Physiology 57 737-769
52. Gu Y, Turck CW and Morgan DO (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366 707-710
53. Hall PA, Kearsey JM, Coates PJ, Norman DG, Warbrick E and Cox LS (1995) Characterisation of the interaction between PCNA and Gadd45. Oncogene 10 2427-2433
54. Hari KL, Santerre A, Sekelsky JJ, McKim KS, Boyd JB and Hawley RS (1995) The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia-telangiectasia gene. Cell 82 815-821
55. Harnden DG (1994) The nature of ataxia-telangiectasia: problems and perspectives. International Journal of Radiation Biology 66 (Supplement) S13-S19
56. Harper JW and Elledge SJ (1996) Cdk inhibitors in development and cancer. Current Opinion in Genetics and Development 6 56-64
57. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 805-816
58. Harper JW, Elledge SJ, Keyomarsi K et al (1995) Inhibition of cyclin-dependent kinases by p21. Molecular Biology of the Cell 6 387-400
59. Hartley KO, Gell D, Smith GCM et al (1995) DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia-telangiectasia gene product. Cell 82 849-856
60. Hartwell L (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71 543-546
61. Hartwell LH and Kastan MB (1994) Cell cycle control and cancer. Science 266 1821-1828
62. Hecht F and Hecht BK (1990) Cancer in ataxia-telangiectasia patients. Cancer Genetics and Cytogenetics 46 9-19
63. Helliwell SB, Wagner P, Kunz J, Deuter-Reinhard M, Henriquez R and Hall MN (1994) TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Molecular Biology of the Cell 5 105-118
64. Hinds PW (1995) The retinoblastoma tumor suppressor protein. Current Opinion in Genetics and Development 5 79-83
65. Houldsworth J and Lavin MF (1980) Effect of ionizing radiation on DNA synthesis in ataxia-telangiectasia cells. Nuclecic Acids Research 8 3709-3720
66. Hunter T (1995) When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83 1-4
67. Israel A (1995) A role for phosphorylation and degradation in the control of NF-κB activity. Trends in Genetics 11 203-205
68. Jackson SP (1995) Ataxia-telangiectasia at the crossroads. Current Biology 5 1210-1212
69. Jaffrey SR and Snyder SH (1995) Nitric oxide: a neural messenger. Annual Review in Cell Biology 11 417-440
70. Jeggo PA, Taccioli GE and Jackson SP (1995) Menage a trois: double strand break repair, V(D)J recombination and DNA-PK. BioEssays 17 949-957
71. Jung M, Zhang Y, Lee S and Dritschilo A (1995) Correction of radiation sensitivity in ataxiatelangiectasia cells by a truncated IκB-α. Science 268 1619-1621
72. Kaltschmidt B, Baeuerle PA and Kaltschmidt G (1993) Potential involvement of the transcription factor NF-κB in neurological disorders. Molecular Aspects of Medicine 14 171-190
73. Kapp LN and Painter RB (1989) Stable radioresistance in ataxia-telangiectasia cells containing DNA from normal human cells. International Journal of Radiation Biology 56 667-675
74. Kastan MB, Zhan Q, El-Deiry WS et al (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71 587-597
75. Kato R and Ogawa H (1994) An essential gene, ESR1, is required for mitotic cell growth, DNA repair and meiotic recombination in Saccharomyces cerevisiae. Nucleic Acids Research 22 3104-3112
76. Cip1. Oncogene 11 1675-1683
77. Keegan KS, Holzman DA, Plug, AW et al (1996) The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes and Development 10 2423-2437
78. Keith CT and Schreiber SL (1995) PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 270 50-51
79. Khanna KK and Lavin MF (1993) Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 8 3307-3312
80. Khanna KK, Beamish H, Yan J et al (1995) Nature of G1/S cell cycle checkpoint defect in ataxiatelangiectasia. Oncogene 11 609-618
81. Kojis TL, Gatti RA and Sparkes RS (1991) The cytogenetics of ataxia-telangiectasia. Cancer Genetics and Cytogenetics 56 143-156
82. Komatsu K, Okumura Y, Kodama S, Yoshida M and Miller RC (1989) Lack of correlation between radiosensitivitiy and inhibition of DNA synthesis in hybrids (A-T × HeLa). International Journal of Radiation Biology 56 863-867
83. Kouzarides T (1995) Functions of pRb and p53: what's the connection? Trends in Cell Biology 5 448-450
84. Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR and Hall MN (1993) Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73 585-596
85. Kyriakis JM, Banerjee P, Nikolakaki E et al (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369 156-160
86. Lange E, Borresen AL, Chen X et al (1995) Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. American Journal of Human Genetics 57 112-119
87. Lavin MF (1993) Biochemical defects in ataxia-telangiectasia, In: Gatti RA and Painter RB (eds). Ataxia-telangiectasia, pp 235-255, NATO ASI Series, vol H77, Springer-Verlag, Berlin
88. Lavin MF, Khanna KK, Beamish H, Teale B, Hobson K and Watters D (1994) Defect in radiation signal transduction in ataxia-telangiectasia. International Journal of Radiation Biology 66 S151-S156
89. Lavin MF, Khanna KK, Beamish H, Spring K, Watters D and Shiloh Y (1995) Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase. Trends in Biochemical Sciences 20 382-383
90. Lavin MF and Shiloh Y Ataxia-telangiectasia. In: Ochs HD, Smith CI and Puck J (eds). Primary Immunodeficiency Diseases, A Molecular and Genetic Approach. Oxford University Press, Oxford (in press)
91. Lehmann AR ( 1982) The cellular and molecular responses of ataxia-telangiectasia cells to DNA damage, In: Bridges BA and Harnden DG (eds). Ataxia-telangiectasia - A Cellular and Molecular Link between Cancer, Neuropathology and Immune Deficiency, pp 83-102, Wiley and Sons, Chichester
92. Lehmann AR, Arlett CF, Burke JF, Green MHL, James MR and Lowe JE (1986) A derivative of an ataxia-telangiectasia (A-T) cell line with normal radiosensitivity but A-T like inhibition of DNA synthesis. International Journal of Radiation Biology 49 639-643
93. Liou HC and Baltimore D (1995) Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Current Opinion in Cell Biology 5 477-487
94. Lipton SA, Choi YB, Pan ZH et al (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364 626-632
95. Little JB and Nagasawa H (1985) Effect of confluent holding on potentially lethal damage repair, cell cycle progression and chromosomal aberrations in human normal and ataxiatelangiectasia fibroblasts. Radiation Research 101 81-93
96. Liu VF and Weaver DT (1993) The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia-telangiectasia and normal human cells. Molecular and Cellular Biology 13 7222-7231
97. Lu X and Lane DP (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75 765-778
98. Lustig AJ and Petes TD (1986) Identification of yeast mutants with altered telomere structure. Proceedings of the National Academy of Sciences of the USA 83 1398-1402
99. Martin GM, Austad SN and Johnson TE (1996) Genetic analysis of ageing: role of oxidative damage and environmental stresses. Nature Genetics 13 25-34
100. Martin K, Tronche D, Hagemeler C, Sorensen TS, LaThange NB and Kouzarides T (1995) Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375 691-694
101. McConville CM, Byrd PJ, Ambrose HJ and Taylor AMR (1994) Genetic and physical mapping of the ataxia-telangiectasia locus on chromosome 11q22-23. International Journal of Radiation Biology 66 S45-S56
102. McKinnon PJ (1987) Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Human Genetics 75 197-208
103. Meredith MJ and Dodson ML (1987) Impaired glutathione biosynthesis in cultured human ataxia-telangiectasia cells. Cancer Research 47 4576-4581
104. Meyer R, Hatada EN, Hohmann HP et al (1991) Cloning of the DNA-binding subunit of human nuclear factor κB: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor α. Proceedings of the National Academy of Sciences of the USA 88 966-970
105. Meyn MS (1995) Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Research 55 5991-6001
106. Meyn MS, Strasfeld L and Allen C (1994) Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. International Journal of Radiation Biology 66 S141-S149
107. Mirzayans R and Paterson MC (1991) Lack of correlation between hypersensitivity to cell killing and impaired inhibition of DNA synthesis in ataxia-telangiectasia fibroblasts treated with 4-nitroquinoline 1-oxide. Carcinogenesis 12 19-24
108. Mirzayans R, Famulski KS, Enns L, Fraser M and Paterson MC (1995) Characterization of the signal transduction pathway mediating γ ray-induced inhibition of DNA synthesis in human cells: indirect evidence for involvement of calmodulin but not protein kinase C nor p53. Oncogene 11 1597-1605
109. Momand J, Zambetti GP, Olson DC, George D and Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69 1237-1245
110. Morgan JL, Holcomb TM and Morrisey RW (1968) Radiation reaction in ataxia-telangiectasia. American Journal of Diseases of Children 116 557-558
111. Morris C, Mohamed R and Lavin MF (1983) DNA replication and repair in ataxia-telangiectasia cells exposed to bleomycin. Mutation Research 112 67-74
112. Morrow DW, Tagle DA, Shiloh Y, Collins FS and Hieter P (1995) TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia-telangiectasia, is functionally related to the yeast checkpoint gene MEG1. Cell 82 831-840
113. Muller JM, Ziegler-Heitbrock HWL and Baeuerle PA (1993) Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187 233-256
114. Muller R (1995) Transcriptional regulation during the mammalian cell cycle. Trends in Genetics 11 173-178
115. Murnane JP and Kapp LN (1993) A critical look at the association of human genetic syndromes with sensitivity to ionizing radiation. Seminars in Cancer Biology 4 93-104
116. Murnane JP and Schwartz JL (1993) Cell checkpoint and radiosensitivity. Nature 365 22
117. Nagasawa H and Little JB (1983) Comparison of kinetics of X-ray induced cell killing in normal, ataxia-telangiectasia and hereditary retinoblastoma fibroblasts. Mutation Research 109 297-308
118. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362 857-860
119. Painter RB and Young BR (1980) Radiosensitivity in ataxia-telangiectasia: a new explanation. Proceedings of the National Academy of Sciences of the USA 77 7315-7317
120. Pandita TK, Pathak S and Geard C (1995) Chromosome end associations, telomeres and telomerase activity in ataxia-telangiectasia cells. Cytogenetics and Cell Genetics 71 86-93
121. Paterson MC, MacFarlane SJ, Gentner N and Smith BP (1985) Cellular hypersensitivity to chronic γ-radiation in cultured fibroblasts from ataxia-telangiectasia heterozygotes, In: Gatti RA and Swift M (eds). Ataxia-telangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood, pp 73-87, Alan R Liss, New York
122. Paules RS, Levedakou EN, Wilson SJ et al (1995) Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Research 55 1763-1773
123. Peterson RDA, Funkhouser JD, Tuck-Muller CM and Gatti RA (1992) Cancer susceptibility in ataxia-telangiectasia. Leukemia 6 (Supplement 1) 8-13
124. Picksley SM and Lane DP (1994) p53 and Rb: their cellular roles. Current Opinion in Cell Biology 6 853-858
125. Price BD and Park SJ (1994) DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells. Cancer Research 54 896-899
126. Proud CG (1996) p70 S6 kinase: an enigma with variations. Trends in Biochemical Sciences 21 181-185
127. Rosen DR, Siddique T, Patterson D et al (1993) Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 59-62
128. Rotman G, Savitsky K, Vanagaite L et al (1994) Physical and genetic mapping at the ATA/ATC locus on chromosome 11q22-23. International Journal of Radiation Biology 66 S63-S66
129. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P and Snyder SH (1994) RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78 35-43
130. Sabers CJ, Martin MM, Brunn GJ et al (1995) Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. Journal of Biological Chemistry 270 815-822
131. Sanchez I, Hughes RT, Mayer BJ et al (1994) Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-jun. Nature 372 794-798
132. Sasaki MS and Taylor AMR (1994) Dissociation between radioresistant DNA replication and chromosomal radiosensitivity in ataxia-telangiectasia cells. Mutation Research 307 107-113
133. Savitsky K, Bar-Shira A, Gilad S et al (1995a) A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 268 1749-1753
134. Savitsky K, Sfez S, Tagle DA et al (1995b) The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Human Molecular Genetics 4 2025-2032
135. Schmidt HHW and Walter U (1994) NO at work. Cell 78 919-925
136. Schreck R, Albermann K and Baeuerle PA (1992) Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radical Research Communications 17 221-237
137. Scott D, Spreadborough AR and Roberts SA (1994) Radiation-induced G2 delay and spontaneous chromosome aberrations in ataxia-telangiectasia homozygotes and heterozygotes. International Journal of Radiation Biology 66 S157-S163
138. Sedgwick RP and Boder E (1991) Ataxia-telangiectasia, In: Vinken PJ, Bruyn GW and Klawans HL (eds). Handbook of Clinical Neurology, vol 16, pp 347-423, Elsevier, Amsterdam
139. Shafman TD, Saleem A, Kyriakis J, Weichselbaum R, Kharbanda S and Kufe DW (1995) Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation. Cancer Research 55 3242-3245
140. Sheridan RB and Huang PC (1979) Superoxide dismutase and catalase activities in ataxiatelangiectasia and normal fibroblast cell extracts. Mutation Research 61 381-386
141. Sherman ML, Datta R, Hallahan DE, Weichselbaum RR and Kufe DW (1990) Ionizing radiation regulates expression of the c-jun protooncogene. Proceedings of the National Academy of Sciences of the USA 87 5663-5666
142. Shiloh Y (1995) Ataxia-telangiectasia: closer to unraveling the mystery. European Journal of Human Genetics 3 116-138
143. Shiloh Y, Tabor E and Becker Y (1982) The response of ataxia-telangiectasia homozygous and heterozygous skin fibroblasts to neocarzinostatin. Carcinogenesis 3 815-820
144. Shiloh Y, Tabor E and Becker Y (1983) Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanism. Carcinogenesis 4 1317-1322
145. Shiloh Y, Tabor E and Becker Y (1985a) In vitro phenotype of ataxia-telangiectasia (AT) fibroblast strains: clues to the nature of the "AT DNA lesion" and the molecular defect in AT. In: Gatti RA and Swift M (eds). Ataxia-telangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood, pp 111-121, Alan R Liss, New York
146. Shiloh Y, Tabor E and Becker Y (1985b) Cell from patients with ataxia-telangiectasia are abnormally sensitive to the cytotoxic effect of a tumor promoter, phorbol-12-myristate-13-acetate. Mutation Research 149 283-286
147. Siddoo-Atwal C, Haas AL and Rosin MP (1996) Elevation of interferon β-inducible proteins in ataxia-telangiectasia cells. Cancer Research 56 443-447
148. Siebenlist U, Franzoso G and Brown K (1994) Structure, regulation and function of NF-κB. Annual Review of Cell Biology 10 405-455
149. Singh SP and Lavin MF (1990) DNA-binding protein activated by gamma radiation in human cells. Molecular and Cellular Biology 10 5279-5285
150. Singh KK and Samson L (1995) Replication protein A binds to regulatory elements in yeast DNA repair and DNA metabolism genes. Proceedings of the National Academy of Sciences of the USA 92 4907-4911
151. Slichenmyer WJ, Nelson WG, Slebos RJ and Kastan MB (1993) Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Research 53 4164-4168
152. Smith ML, Chen IT, Zhan Q et al (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266 1376-1380
153. Smith PJ, Anderson GO and Watson JV (1985) Abnormal retention of X-irradiation ataxiatelangiectasia fibroblasts in G2 phase of the cell cycle: cellular RNA content, chromatin stability and the effect of 3-amino-benzamide. International Journal of Radiation Biology 47 701-712
154. Spink J, Cohen J and Evans TJ (1995) The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Journal of Biological Chemistry 270 29541-29547
155. Stadtman ER (1992) Protein oxidation and aging. Science 257 1220-1224
156. Stewart N, Hicks GG, Paraskevas F and Mowat M (1995) Evidence for a second cell cycle block at G2/M by p53. Oncogene 10 109-115
157. Stillman B, Bell SP, Dutta A and Marahrens Y (1992) DNA replication and the cell cycle, In: Marsh J (ed). Regulation of the Eukaryotic Cell Cycle, Ciba Foundation Symposium 170, pp 147-160, Wiley, Chichester
158. Sun SC, Ganchi PA, Ballard DW and Greene WC (1993) NF-κB controls expression of inhibitor IκBI: evidence for an inducible autoregulatory pathway. Science 259 1912-1915
159. Swift M, Morrell D, Massey RB and Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. New England Journal of Medicine 325 1831-1836
160. Taylor AMR, Harnden DG, Arlett CF et al (1975) Ataxia-telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258 427-429
161. Taylor AMR, Metcalfe JA and McConville C (1989) Increased radiosensitivity and the basic-defect in ataxia-telangiectasia. International Journal of Radiation Biology 56 677-684
162. Taylor AMR, Byrd PJ, McConville CM and Thacker S (1994) Genetic and cellular features of ataxia-telangiectasia. International Journal of Radiation Biology 65 65-70
163. Teale B, Khanna KK, Singh SP and Lavin MF (1993) Radiation-activated DNA-binding protein constitutively present in ataxia-telangiectasia nuclei. Journal of Biological Chemistry 268 22450-22455
164. Telatar M, Wang Z, Udar N et al (1996) Ataxia-telangiectasia: mutations in cDNA detected by protein truncation screening. American Journal of Human Genetics 59 40-44
165. Thanos D and Maniatis T (1995) NF-κB: a lesson in family values. Cell 80 529-532
166. Tlsty TD, Briot A, Gualberto A et al (1995) Genomic instability and cancer. Mutation Research 337 1-7
167. Uziel T, Savitsky K, Platzer M et al (1996) Genomic organization of the ATM gene. Genomics 33 317-320
168. Vuillaume M. (1987) Reduced oxygen species, mutation, induction and cancer initiation. Mutation Research 186 43-72
169. Waga S, Hannon GJ, Beach D and Stillman B (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369 574-578
170. Ward AJ, Olive PL, Burr AH and Rosin MP (1994) Response of fibroblast cultures from ataxia-telangiectasia patients to reactive oxygen species generated during inflammatory reactions. Environmental and Molecular Mutagenesis 24 103-111
171. White E (1994) p53, guardian of Rb. Nature 371 21-22
172. Wiedau-Pazos M, Goto JJ, Rabizadeh Set al (1996) Altered reactivity of Superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271 515-518
173. Wu X, Bayle JH, Olson D and Levine AJ (1993) The p53-mdm-2 autoregulatory feedback loop. Genes and Development 7 1126-1132
174. Xiao ZX, Chen J, Levine AJ et al (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375 694-698
175. Yi M, Rosin MP and Anderson CK (1990) Response of fibroblast cultures from ataxia-telangiectasia patients to oxidative stress. Cancer Letters 54 43-50
176. Yu BP (1994) Cellular defenses against damage from reactive oxygen species. Physiological Reviews 74 139-162
177. Zakian VA (1995) ATM-related genes: what do they tell us about functions of the human gene? Cell 82 685-687
178. Zhan Q, Bae I, Kastan MB and Fornace AJ (1994) The p53-dependent γ-ray response of GADD45. Cancer Research 54 2755-2760
179. Ziv Y, Bar-Shira A, Jorgensen TJ et al (1995) Human cDNA clones that modify radiomimetic sensitivity of ataxia-telangiectasia (group A) cells. Somatic Cell and Molecular Genetics 21 99-111